Conţinutul numărului revistei |
Articolul precedent |
Articolul urmator |
1130 8 |
Ultima descărcare din IBN: 2020-03-26 22:04 |
SM ISO690:2012 NECULA, Gheorghe, REMIŞ, Vladimir. Eficienţa şi inofensivitatea tratamentului de lungă durată cu bronhodilatatoare şi fenspirid al bolnavilor de bronhopneumopatie cronică obstructivă. In: Curierul Medical, 2010, nr. 3(315), pp. 113-116. ISSN 1875-0666. |
EXPORT metadate: Google Scholar Crossref CERIF DataCite Dublin Core |
Curierul Medical | ||||||
Numărul 3(315) / 2010 / ISSN 1875-0666 | ||||||
|
||||||
Pag. 113-116 | ||||||
|
||||||
Descarcă PDF | ||||||
Rezumat | ||||||
Effectiveness and Safety of Long-Term Treatment with Bronchodilators and Fenspirid in Patients with Chronic Obstructive
Pulmonary Disease
The study included 60 patients with COPD grade II. In the first stage of the study, the patients were monitored during exacerbation of COPD;
in stage 2 – in ambulatory conditions (for 6 months) during clinical remission of the disease. Depending on the administered treatment the patients
were randomized into 3 groups. Group I included 20 patients with COPD who administered bronchodilator Salmeterol, group II – 20 patients
who received the combined drug Seretide, group III – 20 patients with COPD who received Fenspirid. Administration of Seretide and Fenspirid
contributed to a statistically significant decrease of dyspnoea and the concentration of systemic inflammation markers, decreased the frequency
of exacerbations, improved the indices of FEV, enhanced the effectiveness of the basic curative therapy and improved patients’ quality of life. |
||||||
Cuvinte-cheie chronic obstructive pulmonary disease, Fenspirid, Salmeterol, Seretide |
||||||
|
Dublin Core Export
<?xml version='1.0' encoding='utf-8'?> <oai_dc:dc xmlns:dc='http://purl.org/dc/elements/1.1/' xmlns:oai_dc='http://www.openarchives.org/OAI/2.0/oai_dc/' xmlns:xsi='http://www.w3.org/2001/XMLSchema-instance' xsi:schemaLocation='http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd'> <dc:creator>Necula, G.</dc:creator> <dc:creator>Remiş, V.V.</dc:creator> <dc:date>2010-06-01</dc:date> <dc:description xml:lang='en'>Effectiveness and Safety of Long-Term Treatment with Bronchodilators and Fenspirid in Patients with Chronic Obstructive Pulmonary Disease The study included 60 patients with COPD grade II. In the first stage of the study, the patients were monitored during exacerbation of COPD; in stage 2 – in ambulatory conditions (for 6 months) during clinical remission of the disease. Depending on the administered treatment the patients were randomized into 3 groups. Group I included 20 patients with COPD who administered bronchodilator Salmeterol, group II – 20 patients who received the combined drug Seretide, group III – 20 patients with COPD who received Fenspirid. Administration of Seretide and Fenspirid contributed to a statistically significant decrease of dyspnoea and the concentration of systemic inflammation markers, decreased the frequency of exacerbations, improved the indices of FEV, enhanced the effectiveness of the basic curative therapy and improved patients’ quality of life.</dc:description> <dc:description xml:lang='ru'>Эффективность и безопасность длительного применения бронхорасширяющих средств и фенспирида при хронической обструктивной болезни легких Обследовано 60 больных ХОБЛ II степени тяжести. На первом этапе, в период обострения хронической обструктивной болезни легких, проводился мониторинг пациентов в условиях стационара, на втором – в амбулаторных условиях в период клинической ремиссии заболевания (в течение 6 месяцев). В зависимости от метода лечения методом рандомизации были сформированы 3 группы наблюдения. В I группу были включены 20 пациентов с ХОБЛ, получавших бронходилататор Сальметерол, во II группу – 20 пациентов, получавших комбинированный препарат Серетайд, в III группу – 20 пациентов, получавших Фенспирид. Применение в комплексной терапии хронической обструктивной болезни легких препаратов Серетайд и Фенспирид способствовало статистически достоверному уменьшению одышки и концентрации системных маркеров воспаления, улучшению ОФВ1 и снижению частоты обострений.</dc:description> <dc:source>Curierul Medical 315 (3) 113-116</dc:source> <dc:subject>chronic obstructive pulmonary disease</dc:subject> <dc:subject>Salmeterol</dc:subject> <dc:subject>Fenspirid</dc:subject> <dc:subject>Seretide</dc:subject> <dc:title>Eficienţa şi inofensivitatea tratamentului de lungă durată cu bronhodilatatoare şi fenspirid al bolnavilor de bronhopneumopatie cronică obstructivă</dc:title> <dc:type>info:eu-repo/semantics/article</dc:type> </oai_dc:dc>